ArticleMolecular oncology2026

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancer.

Moriah L Cunningham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.